Assisted Living or Memory Care Communities – Which is a Better Choice?

Learn about two common senior living types—assisting living and memory care—and how to determine the best care for your elderly parent or spouse.

What Does Cleveland Clinic Say about the New Alzheimer’s Drug?

Cleveland Clinic recently published an article about a patient who received Aduhelm at the hospital, which served as a clinical trial site.

What’s the Criticism of the New Alzheimer’s Drug?

The controversy surrounding the Biogen drug, including its potential cost, comes against a landscape of massive, unmet need for dementia treatment and a disease that costs the U.S. as much as $259 billion annually. More than six million Americans have Alzheimer’s or another form of dementia, according to estimates from the Alzheimer’s Association, and by 2050 that number could reach over 12 million people at a cost of $1 trillion annually.

Lessen Alzheimer’s Debilitating Impact on Financial Decision Making

If a person close to you has been diagnosed with Alzheimer’s disease, it may be time to address some serious financial questions.

Questions About New FDA Approved Alzheimer’s Drug

The US FDA approved a new drug designed to treat Alzheimer’s Disease earlier this month despite little evidence of its effectiveness. The Los Angeles Times, in their article FDA Approves Much-Debated Alzheimer’s Drug Panned by Experts revealed that an advisory panel tasked with reviewing the drug’s performance in clinical trials recommended that the FDA hold […]